This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Wenbin Kuang - Innovator in Cancer Treatment
Introduction
Wenbin Kuang is an inventor based in Nanjing, China. He is currently associated with Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Although he has not yet been granted any patents, his work focuses on significant advancements in cancer treatment.
Latest Patent Applications
Wenbin Kuang's notable patent application is titled "CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF." This invention discloses a compound represented by a specific general formula or a pharmaceutically acceptable salt thereof. The application details a preparation method for the compound and its use in preventing and/or treating various cancer-related diseases. These include breast cancer, prostate cancer, lung cancer, multiple myeloma, leukemia, gastric cancer, ovarian cancer, colon cancer, liver cancer, pancreatic cancer, and human glioma. The compound is anticipated to be developed into a new generation of anticancer drugs.
Conclusion
Wenbin Kuang is making strides in the field of cancer treatment through his innovative research and patent applications. His contributions hold promise for the development of effective therapies against various forms of cancer.